We show that nanoparticles containing rapamycin can prevent the primary immune response to FVIII.
We show that nanoparticles containing rapamycin can prevent the secondary immune response to FVIII in immunized mice.
Tolerogenic nanoparticle effects are antigen-specific and long-lasting.